RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BCLI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Brainstorm Cell Therapeutics Inc. stock price on Wednesday moving between $0.510 and $0.686
(Updated on Mar 27, 2024)

Buy or Hold candidate since Mar 19, 2024 Gain 68.74% PDF

The Brainstorm Cell Therapeutics Inc. stock price fell by -9.06% on the last day (Wednesday, 27th Mar 2024) from $0.660 to $0.600. During the last trading day the stock fluctuated 34.57% from a day low at $0.510 to a day high of $0.686. The price has risen in 6 of the last 10 days and is up by 81.55% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -221 thousand shares and in total, 1 million shares were bought and sold for approximately $760.63 thousand.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $0.663 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 34.26% during the next 3 months and, with a 90% probability hold a price between $0.455 and $0.89 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BCLI Signals & Forecast

The Brainstorm Cell Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.547 and $0.389. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, March 26, 2024, and so far it has fallen -9.06%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.570 and $0.507. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Brainstorm Cell Therapeutics Inc. finds support just below today's level at $0.570. If this is broken, then the next support from accumulated volume will be at $0.507 and $0.480.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.176 between high and low, or 34.57%. For the last week the stock has had daily average volatility of 30.93%.

Our recommended stop-loss: $0.567 (-5.52%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (BCLI) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Brainstorm Cell Therapeutics Inc. to open at $0.599, and during the day (based on 14 day Average True Range), to move between $0.519 and $0.681, which gives a possible trading interval of +/-$0.0812 (+/-13.52%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 27.05% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.570 (5.03%) than the resistance at $0.655 (9.13%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Brainstorm Cell Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Brainstorm Cell Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 2.591 Buy Candidate Upgraded

Predicted Opening Price for Brainstorm Cell Therapeutics Inc. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$0.599 ( 0.228%) $0.600

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BCLI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.775 29.15 %
R2 0.708 17.93 %
R1 0.666 10.99 %
Current price: 0.600
Support S1 0.531 -11.45 %
S2 0.490 -18.38 %
S3 0.423 -29.60 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0.660 9.96 %
R1 0.655 9.13 %
Current price 0.600
Support S1 0.570 -5.03%
S2 0.507 -15.53%
S3 0.480 -20.03%

FAQ

What is the symbol for Brainstorm Cell Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Brainstorm Cell Therapeutics Inc. is BCLI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Brainstorm Cell Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Brainstorm Cell Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Brainstorm Cell Therapeutics Inc. Stock?
Brainstorm Cell Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Brainstorm Cell Therapeutics Inc. Stock.

What's the current price of Brainstorm Cell Therapeutics Inc. Stock?
As of the end of day on the 2024-03-27, the price of an Brainstorm Cell Therapeutics Inc. (BCLI) share was $0.600.

What is the 52-week high and low for Brainstorm Cell Therapeutics Inc. Stock?
The 52-week high for Brainstorm Cell Therapeutics Inc. Stock is $3.46 and the 52-week low is $0.135.

What is the market capitalization of Brainstorm Cell Therapeutics Inc. Stock?
As of the 2024-03-27, the market capitalization of Brainstorm Cell Therapeutics Inc. is 29.399M.

When is the next earnings date for Brainstorm Cell Therapeutics Inc.?
The upcoming earnings date for Brainstorm Cell Therapeutics Inc. is Apr 04, 2024.
Click to get the best stock tips daily for free!

About Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative ... BCLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT